Indici bursieri Piețe bursiere Simboluri Statistici

Simbol EBS
Emergent BioSolutions Inc.

luni, 27 mai 2024, ora 09:22:00 EEST (UTC + 3)

Simbol EBS
Simbol EBS
Simbol eToro EBS
MarketWatch EBS
Finviz EBS
Yahoo Finance EBS
Google Finance EBS
TradingView EBS EBS
Denumire Emergent BioSolutions Inc.
Piața NYSE
ISIN US29089Q1058
Sector Health Technology
Industrie Pharmaceuticals Major
Monedă USD
Preț 8,2500 USD
Capitalizare bursieră 0,416 mld. USD
P/E -1,02
Beta 1,4094
EPS -8,0540
Profit anual -70,94%
Dată actualizare 12.06.2023

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It offers specialty products for civilian and military populations that address accidental, intentional and naturally occurring public health threats. The firm's products include ACAM2000, BioThrax, Raxibacuma, Vaxchora, and VIGIV. Its business units include Vaccines and Anti-Infectives; Antibody Therapeutics; Devices; and Contract Development and Manufacturing. The company was founded by Fuad El-Hibri in May 1998 and is headquartered in Gaithersburg, MD.

Istoric cotații

Data P/E Beta Capitalizare Dividend EPS Profit anual Preț
29.11.2021 10,59 1,0406 2,380 0,00% 4,1758 -46,26% $44,21
12.06.2023 -1,02 1,4094 0,416 0,00% -8,0540 -70,94% $8,25

Pagină vizualizată de 71 ori și generată în 0,018583 secunde.